ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMGastos comerciales, generales y administrativos45.43 M57.9 M46.66 M48.08 M44.92 M197.56 MInvestigación y desarrollo——————Beneficio operativo125.38 M113.52 M126.33 M141.81 M153.27 M534.93 MTotal de ingresos no operativos8.5 M4.65 M-1.8 M1.03 M3.56 M7.44 MGastos por intereses, netos de intereses capitalizados——————Ingresos no operativos, una vez deducidos los gastos por intereses7.88 M6.46 M1.08 M1.52 M3.72 M12.78 MIngresos/gastos extraordinarios621 K-1.82 M-2.88 M-489 K-158 K-5.34 MBeneficio antes de impuestos133.88 M118.17 M124.54 M142.84 M156.83 M542.38 MParticipación en los beneficios——————Impuestos16.86 M3.58 M34.28 M31.7 M21.7 M91.25 MParticipación minoritaria——————Otros ingresos/gastos después de impuestos173 K502 K18 K-87 K442 K875 KBeneficio neto antes de actividades interrumpidas117.02 M114.59 M90.26 M111.14 M135.13 M451.12 MOperaciones suspendidas——————Beneficio neto117.02 M114.59 M90.26 M111.14 M135.13 M451.12 MAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas117.02 M114.59 M90.26 M111.14 M135.13 M451.12 MBeneficio básico por acción3.783.773.163.954.7615.64Beneficio por acción diluido3.673.673.13.864.6515.28Número medio de acciones ordinarias30.96 M30.39 M28.6 M28.14 M28.85 M115.97 MAcciones diluidas32.01 M31.2 M29.14 M28.82 M29.53 M118.68 MEBITDA133.97 M120.45 M133.35 M148.86 M161.11 M563.77 MEBIT125.38 M113.52 M126.33 M141.81 M153.27 M534.93 MCosto de los ingresos358.27 M380.22 M423.3 M462.96 M503.13 M1.77 BOtros costes de producción358.27 M380.22 M423.3 M462.96 M503.13 M1.77 BAmortización y depreciación (flujo de caja)8.59 M6.93 M7.01 M7.05 M7.84 M28.83 M
Medpace Holdings Inc
Medpace Holdings, Inc. is a global clinical research organization based in Cincinnati, Ohio, employing approximately 6,000 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
The company started trading stock as a public firm in 2016.